| 1 |
1 |
Genetics of Opioid Dependence |
Joel Gelernter |
Opioid-Cocaine Dependence |
Opioid-Cocaine Dependence |
4,848 |
NIDA Repository |
| 2 |
2 |
Mapping Susceptibility Genes for Nicotine Dependence |
Ming D. Li |
Nicotine Dependence |
Nicotine Dependence |
1,962 |
NIDA Repository |
| 3 |
3 |
Molecular Genetics of Heroin Dependence in China |
Ming Tsuang |
Opioid Dependence |
Opioid Dependence |
1,232 |
NIDA Repository, dbGaP |
| 4 |
5 |
Addictions, Genotypes, Polymorphisms, and Function |
Mary Jeanne Kreek |
Opioid Dependence |
Opioid Dependence |
1,751 |
NIDA Repository, dbGaP |
| 5 |
6 |
The Genetics of Vulnerability to Nicotine |
Pamela Madden |
Nicotine Dependence |
Nicotine Dependence |
2,663 |
NIDA Repository, dbGaP |
| 6 |
7 |
An Introduction to the Family Study of Cocaine |
Laura Bierut |
Cocaine Dependence |
Cocaine Dependence |
1,049 |
NIDA Repository, dbGap |
| 7 |
8 |
Mu Opioid Receptor Gene in Heroin Addicts |
Lei Yu |
Opioid Dependence |
Opioid Dependence |
|
Combined with Study 5 |
| 8 |
9 |
Differentiation of Phenotypes for Smoking: Administrative Supplement to Join NIDA Genetics Consortium |
Ovide Pomerleau |
Nicotine Dependence |
Nicotine Dependence |
1,540 |
NIDA Repository |
| 9 |
10 |
Pharmacokinetics of Nicotine in Twins |
Gary Swan |
Nicotine Dependence |
Nicotine Dependence |
62 |
NIDA Repository |
| 10 |
11 |
Adolescent Drug Dependence |
John Hewitt |
Polysubstance Dependence |
Polysubstance Dependence |
1,589 |
NIDA Repository, dbGap |
| 11 |
12 |
Substance Abuse and the Dopamine System Genes |
Michael M. Yanyukov |
Polysubstance Dependence |
Polysubstance Dependence |
470 |
NIDA Repository |
| 12 |
13 |
Genetics of Cocaine Induced Psychosis |
Joseph F. Cubells |
Cocaine Dependence |
Cocaine Dependence |
230 |
NIDA Repository |
| 13 |
14 |
Genome-Wide Analysis for Addiction Susceptibility Genes |
Herb Lachman |
Opioid Dependence |
Opioid Dependence |
693 |
NIDA Repository, dbGaP |
| 14 |
15 |
Nicotine Dependence |
Laura Bierut |
Nicotine Dependence |
Nicotine Dependence |
3,424 |
NIDA Repository, dbGap |
| 15 |
16 |
Nicotine Dependence |
Mark Leppert |
Nicotine Dependence |
Nicotine Dependence |
917 |
NIDA Repository |
| 16 |
17 |
Opioid Dependence |
Wade Berrettini |
Opioid Dependence |
Opioid Dependence |
200 |
NIDA Repository, dbGaP |
| 17 |
18 |
Opioid Dependence: Candidate Genes and G x E Effects |
Elliot Nelson |
Opioid Dependence |
Opioid Dependence |
1,895 |
NIDA Repository, dbGaP |
| 18 |
19 |
Epidemiological Study of Substance Abuse |
Rob Philibert |
Polysubstance Dependence |
Polysubstance Dependence |
520 |
NIDA Repository |
| 19 |
20 |
Innovative Approaches for Cocaine Pharmacotherapy |
Henry Kranzler |
Opioid-Cocaine Dependence |
Opioid-Cocaine Dependence |
219 |
NIDA Repository |
| 20 |
21 |
Twin Family Study of Vulnerability to Substance Abuse |
William Iacono |
Polysubstance Dependence |
Polysubstance Dependence |
|
Combined with Study 25 |
| 21 |
22 |
Exploring the Genetic Basis for Drug Use |
Hallam Hurt |
Polysubstance Dependence |
Polysubstance Dependence |
|
Closed |
| 22 |
23 |
Substance Use Disorder Liability: Candidate Gene System |
Michael M. Vanyukov |
Polysubstance Dependence |
Polysubstance Dependence |
886 |
NIDA Repository |
| 23 |
24 |
START Pharmacogenetics: Exploratory Genetic Studies in Starting Treatment with Agonist Replacement Therapies (START); CTN-0027 |
Wade Berrettini |
Opioid Dependence |
Opioid Dependence |
785 |
NIDA Repository, dbGaP, Clinial Trials Network |
| 24 |
25 |
The Genes, Environment, and Development Initiative (GEDI) |
William Iacono |
Other |
Other |
|
dbGaP |
| 25 |
26 |
The Genes, Environment, and Development Initiative (GEDI) |
E. Jane Costello |
Other |
Other |
|
dbGaP |
| 26 |
27 |
The Genetic Study of Nicotine Dependence in African Americans (AAND) |
Laura Bierut |
Nicotine Dependence |
Nicotine Dependence |
1,792 |
NIDA Repository, dbGaP |
| 27 |
28 |
Center on Antisocial Drug Dependence: the Genetics of HIV Risk Behavior |
John Hewitt |
Other |
Other |
|
NIDA Repository*, dbGaP |
| 28 |
29 |
Genetics Protocol of the Cocaine Use Reduction with Buprenorphine (CURB) Study; CTN-0048 |
David A. Nielsen |
Cocaine Dependence |
Cocaine Dependence |
278 |
NIDA Repository, Clinical Trials Network |
| 29 |
30 |
Phase 2: Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Trial of Nepicastat for Cocaine Dependence |
Thomas R. Kosten |
Cocaine Dependence |
Cocaine Dependence |
|
NIDA Repository* |
| 30 |
31 |
Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT); CTN-0051 |
John Rotrosen |
Smokescreen |
Smokescreen |
615 |
dbGaP, Clinical Trials Network |
| 31 |
32 |
Achieving Cannabis Cessation-Evaluation of N-Acetylcysteine (ACCENT); CTN-0053 |
Kevin Gray |
Cannabis Dependence |
Cannabis Dependence |
201 |
NIDA Repository, Clinical Trials Network |
| 32 |
33 |
Genome-wide Association Study of HIV-1 Host Genetics Among Injection Drug Users |
Eric Johnson |
Other |
Other |
|
dbGaP |
| 33 |
34 |
Attention Deficit-Hyperactivity Disorder (ADHD) |
Robert K. Moyzis |
Other |
Other |
|
NIDA Repository* |
| 34 |
35 |
Genetically Informative Smoking Cessation Trial |
Li-Shiun Chen |
Nicotine Dependence |
Nicotine Dependence |
873 |
NIDA Repository |
| 35 |
36 |
Genetic Dissection in Pedigrees of Substance Use and Mood Disorders Comorbidity |
Nelson B. Freimer |
Other |
Other |
|
NIDA Repository* |
| 36 |
37 |
Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder; CTN-0068 |
Madhukar Trivedi |
Methamphetamine Dependence |
Methamphetamine Dependence |
243 |
NIDA Repository, Clinical Trials Network |
| 37 |
38 |
Adolescent Brain Cognitive Development (ABCD) Study |
|
Other |
Other |
10,217 |
NIMH Data Archive |
| 38 |
39 |
Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone: Improving the Real-World Effectiveness of Injection Naltrexone for Opioid Use Disorder (SWIFT); CTN-0097 |
Adam Bisaga |
Opioid Dependence |
Opioid Dependence |
246 |
Clinical Trials Network* |
| 39 |
40 |
Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTREY); CTN-0098 |
Gavin Bart |
Opioid Dependence |
Opioid Dependence |
15 |
Clinical Trials Network* |
| 40 |
41 |
Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy; CTN-0100 |
Edward Nunes |
Opioid Dependence |
Opioid Dependence |
472 |
Clinical Trials Network* |
| 41 |
42 |
Genetics Analysis of Substance Use Disorder Using the Indiana Biobank Data |
Dongbing Lai |
Other |
Smokescreen |
|
dbGaP |
| 42 |
43 |
Pediatric Imaging, Neurocognition, and Genetics (PING) |
Terry Jernigan |
Other |
Other |
|
TBA |
| 43 |
44 |
Randomized, Placebo-Controlled Trial of Injectable Naltrexone and Monthly Injectable Buprenorphine for Cocaine Use Disorder (CURB-2); CTN-0109 |
Madhukar Trivedi |
Cocaine Dependence |
Cocaine Dependence |
|
Clinical Trials Network* |
| 44 |
45 |
Randomized, Double-Blind, Placebo-Controlled Trial of Monthly Injectable Buprenorphine for Methamphetamine Use Disorder (MURB); CTN-0110 |
Steve Shoptaw |
Polysubstance Dependence |
Polysubstance Dependence |
|
Closed |
| 45 |
46 |
Advancing Genomics Research of Substance Use Disorders in Latin American Populations |
Janitza Montalvo-Ortiz & Humberto Nicolini |
NIDA Sequencing Inititative |
NIDA Sequencing Inititative |
|
dbGaP |
| 46 |
51 |
Genotyping on Smokescreen Microarray Chip |
Jasmin Vassileva & Alexandre Todorov |
Smokescreen |
Smokescreen |
|
dbGaP studies: phs001647, phs001804 |
| 47 |
52 |
Genetic Contribution to the Abuse Liability of Oxycodone |
Jermaine Jones |
Smokescreen |
Smokescreen |
|
dbGaP |
| 48 |
53 |
The Women’s Interagency HIV Study (WIHS) |
Brad Aouizerat |
Smokescreen |
Smokescreen |
|
dbGaP |
| 49 |
54 |
Genotyping on Smokescreen Microarray Chip |
Deborah Mash |
Smokescreen |
Smokescreen |
|
dbGaP |
| 50 |
55 |
ALIVE Cohort Smokescreen GWAS |
Brion Maher |
Smokescreen |
Smokescreen |
|
dbGaP |
| 51 |
56 |
Assess the Cardiovascular, Cognitive, and Subjective Effects of Atomoxetine in Combination with IV Methamphetamine |
Edythe London |
Smokescreen |
Smokescreen |
|
dbGaP |
| 52 |
57 |
Neural Systems, Inhibitory Control, and Methamphetamine Dependence |
Edythe London |
Smokescreen |
Smokescreen |
|
dbGaP |
| 53 |
58 |
Early Methamphetamine Abstinence fMRI and Brain Function |
Edythe London |
Smokescreen |
Smokescreen |
|
dbGaP |
| 54 |
59 |
Smokescreen; Opioid/Cocaine Use; Antisocial Drug Dependence |
Robin Corley |
Smokescreen |
Smokescreen |
|
dbGaP |
| 55 |
60 |
Gene-Environment Interactions in COCCaINE Use Disorder: Collaborative Case-Control Initiative in Cocaine Addiction |
Rodrigo Grassi-Oliveira |
Smokescreen |
Smokescreen |
|
dbGaP |
| 56 |
61 |
Smokescreen; NJD/NID Cohort |
Stanley Weiss |
Smokescreen |
Smokescreen |
|
dbGaP |
| 57 |
62 |
Prevention of Viral Hepatitis and HIV in Drug Users – A Hepatitis B Model for HIV and an HB Vaccine Model (DASH) |
Lu-Yu Hwang |
Smokescreen |
Smokescreen |
|
dbGaP |
| 58 |
63 |
Smokescreen; InC3 Cohort Substance Abusers |
Kimberly Page |
Smokescreen |
Smokescreen |
|
dbGaP |
| 59 |
64 |
Smokescreen; Centers for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS) |
Inga Peter |
Smokescreen |
Smokescreen |
|
dbGaP |
| 60 |
65 |
Spit for Science |
Danielle Dick |
Smokescreen |
Smokescreen |
|
dbGaP |
| 64 |
47 |
Study 47 – Ketamine for Methamphetamine Use Disorder (KMD); CTN-0132 |
Madhukar H. Trivedi |
Methamphetamine Dependence |
Methamphetamine Dependence |
|
Clinical Trials Network* |
| 65 |
48 |
Study 48 – Methamphetamine and Other Substance Use Disorder Genetics in Thailand |
Joel Gelernter |
Methamphetamine Dependence |
NIDA Sequencing Initiative |
|
TBA |
| 66 |
71 |
COGA Project |
Howard Edenberg |
Other |
NIDA Sequencing Inititative |
|
phs000763.v2.p1, phs000976.v3.p1, phs001208.v3.p1 |